(63 days)
Philips IntelliVue reusable ECG lead sets/trunk cables and Philips OR ECG trunk cables are indicated for continuous monitoring of cardiac signals for both diagnostic and monitoring purposes. These devices are limited by the indications for use of the connected monitoring and diagnostic equipment in healthcare facilities. These devices are intended to interact with patient intact skin only.
Philips Reusable ECG Lead Sets and Trunk Cables are non-invasive reusable medical devices designed to transfer ECG signals from the patient to the monitor used in the healthcare facilities, which includes intensive care unit (ICU) for both adults and neonates and the operating room (OR). The ECG cables and lead sets are used to forward an electrical cardiac signal via electrical wires from the electrode attached on patient skin to the ECG measurement hardware in the patient monitor and to support other outputs as needed. The portfolio consists of two types of trunk cables and two types of lead sets: ICU and OR, including various electrode connectors with AAMI and IEC coloring. The ECG Trunk cables and lead sets are suitable for multiple patient use. The Philips Reusable ECG Lead Sets and Trunk Cables have a service life of 18 months. The Philips Reusable ECG Lead Sets and Trunk Cables can be used with any Philips monitors including Philips monitor/defibrillator product lines and Philips monitoring or diagnostic equipment which claim compatibility to Philips Reusable ECG Lead Sets and Trunk Cables.
This document is a 510(k) premarket notification for Philips Reusable ECG Lead Sets and Trunk Cables. It focuses on demonstrating substantial equivalence to a predicate device, rather than proving performance against specific acceptance criteria through a standalone study with clinical accuracy metrics. Therefore, many of the requested details about acceptance criteria, clinical study design, and ground truth are not applicable or explicitly stated in this type of submission.
However, I can extract the information that is present regarding performance testing and standards.
1. Table of Acceptance Criteria and Reported Device Performance
Instead of specific quantitative clinical acceptance criteria and device performance metrics, this submission relies on compliance with recognized harmonized standards. The "performance" is demonstrated through successful completion of tests outlined in these standards.
| Acceptance Criteria (Compliance with Standard) | Reported Device Performance |
|---|---|
| IEC 60601-1:2005+A1:2012+A2:2020 (Medical electrical equipment – Part 1: General requirements for basic safety and essential performance) | The subject devices have passed all safety tests for demonstrated compliance with this recognized standard. |
| ANSI AAMI EC53:2013/(R)2020 (ECG trunk cables and patient lead wires) | The subject devices have passed all safety tests for demonstrated compliance with this recognized standard. |
| IEC 60601-2-25:2011/(R)2016 (Medical electrical equipment - Part 2-25: Particular requirements for the basic safety and essential performance of electrocardiographs) | The subject devices have passed all safety tests for demonstrated compliance with this recognized standard. |
| IEC 60601-2-27:2011(R)2016 (Medical electrical equipment - Part 2-27: Particular requirements for the basic safety and essential performance of electrocardiographic equipment) | The subject devices have passed all safety tests for demonstrated compliance with this recognized standard. |
| IEC 60601-1-12 Edition 1.1 2020-07 CONSOLIDATED VERSION (Medical electrical equipment - Part 1-12: General requirements for basic safety and essential performance - Collateral Standard: Requirements for medical electrical equipment and medical electrical systems intended for use in the emergency medical services environment) | The subject devices have passed all safety tests for demonstrated compliance with this recognized standard. (Specifically, ICU Lead Sets and Trunk cables comply with this additional standard). |
| IEC 62366-1:2015+AMD1:2020: (Part 1: Application of usability engineering to medical devices) | The subject devices have passed all safety tests for demonstrated compliance with this recognized standard. |
| Reprocessing Standards: ISO 17664-2:2021, AAMI TIR12 (2020)/(R)2023, and ANSI AAMI ST98:2022, and FDA guidance "Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling" | The subject device adheres to these standards, and its proposed reprocessing instructions are as effective as the predicate device, meeting regulatory requirements for reusable devices. |
| Biocompatibility: (ISO 10993-1, as inferred from comparison to predicate) | Both the subject and predicate devices meet standards for biocompatibility. |
| Electrical Conductivity, Mechanical Strength: (as inferred from comparison to predicate) | Both the subject and predicate devices meet standards for electrical conductivity and mechanical strength. |
2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)
This document explicitly states: "The subject devices, like the primary predicate devices, did not require clinical trials." Therefore, there is no "test set" in the context of a clinical study for external validation of performance. Performance is primarily demonstrated through compliance with recognized standards via non-clinical bench testing. The data provenance would be from internal lab testing, not patient data.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)
Not applicable. No clinical test set requiring expert ground truth was used as per the statement above.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set
Not applicable. No clinical test set requiring expert adjudication was used.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This device is an ECG cable and lead set, a hardware accessory. It is not an AI algorithm for interpreting medical images or signals, nor does it involve "human readers" or "AI assistance" in that sense.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
Not applicable. This is a hardware accessory, not an algorithm. Performance is assessed through its physical and electrical properties, not algorithmic output.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
Not applicable in the sense of clinical ground truth. For non-clinical bench testing, the "ground truth" would be established by the specifications and measurement techniques defined within the harmonized standards (e.g., electrical resistance, mechanical durability measured against stated tolerances, biocompatibility testing results).
8. The sample size for the training set
Not applicable. This is a hardware accessory, not a machine learning model, so there is no training set.
9. How the ground truth for the training set was established
Not applicable. There is no training set.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image contains the logos of the Department of Health and Human Services and the Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo includes the letters "FDA" in a blue square, followed by the words "U.S. Food & Drug Administration" in blue text.
January 17, 2025
Philips Medizin Systeme Böblingen GmbH Namita Nandurkar Regulatory Affairs Specialist Hewlett-Packard-Str. 2 Böblingen, BW 71034 Germany
Re: K243545
Trade/Device Name: Philips Reusable ECG Lead Sets and Trunk Cables : Model Number,Model Name: 989803170171, OR 3-Lead ECG Trunk Cable, AAMI/IEC; 989803170181, OR 5-Lead ECG Trunk Cable, AAMI/IEC; M1667A, 6 Lead ECG Trunk, AAMI/IEC 2.7m; M1668A,5 Lead ECG Trunk, AAMI/IEC 2.7m; M1669A,3 Lead ECG Trunk, AAMI/IEC 2.7m; M1949A,5+5 ECG Trunk cable AAMI, IEC 2.7m; M1663A.10 Lead ECG Trunk AAMI/IEC 2m; M1665A, 6+4 Lead ECG Trunk AAMI/IEC 2.7m; M1671A, 3 Leadset, Grabber, AAMI, ICU; M1673A, 3 Leadset, Snap, AAMI, ICU; M1675A, 3 Leadset, Grabber, AAMI, OR; M1624A, Unshielded 3 Ld Miniclip AAMI; M1532A, 4 Lead Set Grabber AAMI, ICU: M1968A, 5 Leadset, Grabber, AAMI, ICU: M1644A, 5 Leadset, Snap, AAMI, ICU; M1973A, 5 Leadset, Grabber, AAMI, OR; M1976A, 5 Leadset, Grabber, Chest, AAMI, ICU; M1602A, 5 Lead Snap Chest AAMI, ICU; M1979A, 5 Leadset, Grabber, Chest, AAMI, OR; M1680A, 6 Lead Set Grabber AAMI, ICU Regulation Number: 21 CFR 870.2900 Regulation Name: Patient Transducer And Electrode Cable (Including Connector) Regulatory Class: Class II Product Code: DSA Dated: July 19, 2024 Received: November 15, 2024
Dear Namita Nandurkar:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination
{1}------------------------------------------------
product submissions. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rue"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part
{2}------------------------------------------------
803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jennifer W. Shih -S
Jennifer Kozen Assistant Director Division of Cardiac Electrophysiology, Diagnostics, and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
Indiantions for I los
| Indications for Use |
|---|
| Submission Number (if known) |
| K243545 |
| Device Name |
| Philips Reusable ECG Lead Sets and Trunk Cables :Model Number,Model Name:989803170171, OR 3-Lead ECG Trunk Cable, AAMI/IEC; |
| 989803170181, OR 5-Lead ECG Trunk Cable, AAMI/IEC; |
| M1667A, 6 Lead ECG Trunk, AAMI/IEC 2.7m; |
| M1668A,5 Lead ECG Trunk, AAMI/IEC 2.7m; |
| M1669A,3 Lead ECG Trunk, AAMI/IEC 2.7m; |
| M1949A,5+5 ECG Trunk cable AAMI, IEC 2.7m; |
| M1663A, 10 Lead ECG Trunk AAMI/IEC 2m; |
| M1665A, 6+4 Lead ECG Trunk AAMI/IEC 2.7m; |
| M1671A, 3 Leadset, Grabber, AAMI, ICU; |
| M1673A, 3 Leadset, Snap, AAMI, ICU; |
| M1675A, 3 Leadset, Grabber, AAMI, OR; |
| M1624A, Unshielded 3 Ld Miniclip AAMI; |
| M1532A, 4 Lead Set Grabber AAMI, ICU; |
| M1968A, 5 Leadset, Grabber, AAMI, ICU; |
| M1644A, 5 Leadset, Snap, AAMI, ICU; |
| M1973A, 5 Leadset, Grabber, AAMI, OR; |
| M1976A, 5 Leadset, Grabber, Chest, AAMI, ICU; |
| M1602A, 5 Lead Snap Chest AAMI, ICU; |
| M1979A, 5 Leadset, Grabber, Chest, AAMI, OR; |
| M1680A, 6 Lead Set Grabber AAMI, ICU |
Indications for Use (Describe)
Philips IntelliVue reusable ECG lead sets/trunk cables and Philips OR ECG trunk cables are
{4}------------------------------------------------
indicated for continuous monitoring of cardiac signals for both diagnostic and monitoring purposes. These devices are limited by the indications for use of the connected monitoring and diagnostic equipment in healthcare facilities. These devices are intended to interact with patient intact skin only.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame.
| 510(k) Summary | ||||
|---|---|---|---|---|
| Submitter | ||||
| Date Prepared | October 29, 2024 | |||
| Submitter/Owner | Philips Medizin Systeme Böblingen GmbHFDA Establishment Number 9610816Hewlett-Packard-Str. 271034 BöblingenGermany | |||
| Key Contact | Namita NandurkarRegulatory Affairs Specialistnamita.nandurkar@philips.comPhone: +49 17668210269 | |||
| 510(k) Submission Type | This is a traditional 510(k). | |||
| Device | ||||
| Trade Name | Philips Reusable ECG Lead Sets and Trunk Cables | |||
| Common Name | ECG Cables and Lead Sets | |||
| Classification Name | Panel & Name: Cardiovascular DevicesSubpart & Division: 21 CFR §870.2900Regulatory Class: IIProduct Code: DSA | |||
| Predicate Device and Reference Device | ||||
| 510(k) No. | Company | Device Name | ProductCode | |
| Predicate Device | K181726 | MedlineIndustries,Inc | Medline Patient Cables and Lead Wires | DSA |
| Reference Device | K211294 | VyaireMedical,Inc. | Multi-Link X2 ECG Cable and Lead wireSystem | DSA |
Image /page/5/Picture/4 description: The image shows the Philips logo, which is a blue shield shape with the word "PHILIPS" in white at the top. Inside the shield, there are two wavy lines and two four-pointed stars. The overall design is simple and recognizable, representing the brand's identity.
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame. The background is white.
Device Description
Philips Reusable ECG Lead Sets and Trunk Cables – description of the device per 21 CFR 807.92(a) (4)
Philips Reusable ECG Lead Sets and Trunk Cables are non-invasive reusable medical devices designed to transfer ECG signals from the patient to the monitor used in the healthcare facilities, which includes intensive care unit (ICU) for both adults and neonates and the operating room (OR). The ECG cables and lead sets are used to forward an electrical cardiac signal via electrical wires from the electrode attached on patient skin to the ECG measurement hardware in the patient monitor and to support other outputs as needed. The portfolio consists of two types of trunk cables and two types of lead sets: ICU and OR, including various electrode connectors with AAMI and IEC coloring. The ECG Trunk cables and lead sets are suitable for multiple patient use. The Philips Reusable ECG Lead Sets and Trunk Cables have a service life of 18 months. The Philips Reusable ECG Lead Sets and Trunk Cables can be used with any Philips monitors including Philips monitor/defibrillator product lines and Philips monitoring or diagnostic equipment which claim compatibility to Philips Reusable ECG Lead Sets and Trunk Cables.
Intended Use and Indication for Use
Intended Use as required per 21 CFR 807.92(a)(5)
Intended Use:
Philips IntelliVue Reusable ECG lead sets and trunk cables are limited by the indications for use of the connected monitoring and diagnostic equipment and are for use only by healthcare professionals. They are designed for multiple patient use and indicated for monitoring cardiac signals for both diagnostic and monitoring purposes in adult, pediatric, and neonatal patients. Philips operating room (OR) ECG trunk cables are indicated for use to monitor patient ECG in an electrosurgery (ESU) environment when used in combination with a compatible ECG patient lead set on adult, pediatric, infant, and neonatal ECG applications.
Indications for Use:
Philips IntelliVue reusable ECG lead sets/trunk cables and Philips OR ECG trunk cables are indicated for continuous monitoring of cardiac signals for both diagnostic and monitoring purposes. These devices are limited by the indications for use of the connected monitoring and diagnostic equipment in healthcare facilities. These devices are intended to interact with patient intact skin only.
Image /page/6/Picture/12 description: The image shows the Philips logo, which is a blue shield shape. Inside the shield, there are two wavy lines and two four-pointed stars. The word "PHILIPS" is written in white at the top of the shield.
{7}------------------------------------------------
Comparison of Intended Uses for Subject Device and Predicate
The intended use of the subject device is worded slightly differently from that of the predicate device, but they serve the same general purpose based on the following points:
- Connection to Monitoring and Diagnostic Equipment: Both the subject and predicate devices are designed to connect to patient monitoring systems, ensuring secure and reliable signal transmission.
- . Usage by Healthcare Professionals: Both devices are used exclusively by healthcare professionals in clinical settings.
- . Intended for Monitoring and Diagnostic Purposes: Both devices are intended solely for monitoring and diagnostic purposes, facilitating the evaluation of patient health.
The subject and predicate devices are considered accessories, as defined by the FDA. An accessory is a finished device intended to support, supplement, and/or augment the performance of one or more parent devices. These devices support the performance of parent devices by enabling or facilitating those devices to perform according to their intended use. Both the subject and predicate devices function as accessories to patient monitoring systems by providing reliable connections between the patient and the monitoring/diagnostic equipment. Therefore, the subject device's general purpose and intended use are identical to the predicate device.
- . Subject Device Intended Use: Philips IntelliVue reusable ECG lead sets and trunk cables are limited by the indications for use of the connected monitoring and diagnostic equipment and are for use only by healthcare professionals. They are designed for multiple patient use and indicated for monitoring cardiac signals for both diagnostic and monitoring purposes in adult, pediatric, and neonatal patients. Philips operating room (OR) ECG trunk cables are indicated for use to monitor patient ECG in an electrosurgery (ESU) environment when used in combination with a compatible ECG patient lead set on adult, pediatric, infant and neonatal ECG applications.
- . Predicate Device Intended Use: Medline Patient Cables and Lead Wires are used to connect electrodes and/or sensors placed at the appropriate sites on the patient to a monitoring device for general monitoring and/or diagnostic evaluation by a healthcare professional.
Image /page/7/Picture/11 description: The image is the Philips logo. The logo is a blue shield with the word "PHILIPS" at the top. Inside the shield are two wavy lines and four stars. The stars are arranged in a diamond shape.
{8}------------------------------------------------
Image /page/8/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The letters are all capitalized and evenly spaced. The font is sans-serif and the overall impression is clean and modern.
| Comparison of Technological Characteristics with Predicate Device | |
|---|---|
| Similarities | |
| Item of Comparison | Description/Rationale |
| Indications for Use | The indications for use are worded slightly differently but are essentially identicalbased on the following points:Both devices are connected to electrodes to monitor and diagnoseelectrocardiogram (ECG) signals. Both devices are connected to monitoring and diagnostic equipment. The general purpose and intended use of the subject and predicate devicesare identical. The indications for use for both the subject and predicate devices are wordeddifferently, but both are ultimately limited by the indications for the use of theconnected monitoring or diagnostic equipment that monitors the patient's ECG.Subject Device Indications for Use: Philips IntelliVue reusable ECG leadsets/trunk cables and Philips OR ECG trunk cables are indicated for continuousmonitoring of cardiac signals for both diagnostic and monitoring purposes.These devices are limited by the indications for use of the connectedmonitoring and diagnostic equipment in healthcare facilities. These devicesare intended to interact with patient intact skin only. Predicate Device Indications for Use: Medline Patient Cables and Lead Wiresare used to connect electrodes and/or sensors placed at the appropriate siteson the patient to a monitoring device for general monitoring and/ordiagnostic evaluation by a healthcare professional. Additionally, the use ofMedline Patient Cables and Lead Wires is limited by the indications for use ofthe ECG monitoring or diagnostic equipment it is connected to. MedlinePatient Cables and Lead Wires are intended for Prescription Use only. |
| Principle ofOperation | Subject and Predicate Devices emphasize that the operation of the device is confinedto the area from the patient electrodes to the monitoring/diagnostic equipment,providing a means of cable connection for ECG signal transmission. Therefore, thesubject and predicate device are identical. |
| Patient Population | The patient populations between the subject and predicate device are worded slightlydifferently, but they encompass the same patient groups, which are Adult andpediatric. Therefore, the subject and predicate device are identical. |
| Anatomical Sites | The operational and functional characteristics of the subject and predicate devices areidentical, as they both attach to the exact body locations, which are Left arm, Rightarm, Chest, Left leg & Right leg and serve the same purpose. Therefore, the subjectand predicate device are identical. |
| Environment of Use | The subject device (healthcare facility) and predicate device (healthcare settings) areused in identical environments. Therefore, the subject and predicate device areidentical. |
| Sterility | The subject device is identical to the predicate device, as both have nonsterile trunkcables and lead sets. Since neither device requires sterility, they are identical. |
| Prescription Use | The subject and predicate devices are for prescription use and intended for use inidentical environments. Therefore, are identical. |
| Differences | |
| Number of Leadwires in a Lead Set | The subject device includes 4 and 6 lead wire lead sets which is not seen in thepredicate device (includes 3 and 5 lead wire lead sets). This difference does not raisedifferent questions of safety and effectiveness. |
Image /page/8/Picture/4 description: The image shows the Philips logo, which consists of the word "PHILIPS" in blue, positioned above a blue shield-like shape. Inside the shield, there are two wavy lines and four stars. The background of the shield is white.
{9}------------------------------------------------
Image /page/9/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame.
Image /page/9/Picture/4 description: The image shows the Philips logo, which is a blue shield shape. Inside the shield, there are two wavy lines and four stars. The word "PHILIPS" is written in white at the top of the shield.
{10}------------------------------------------------
Image /page/10/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The letters are all capitalized and evenly spaced. The font is sans-serif and the overall impression is clean and modern.
| The subject device is substantially equivalent to the predicate device based on thefollowing points: | |
|---|---|
| • The subject device has reusable lead sets, while the predicate has disposable leadsets. This difference does not raise different questions of safety and effectivenessbecause the core function of transmitting ECG signals remains unchanged, andboth devices are designed to ensure signal transmission. The materials anddesign of the reusable lead sets meet rigorous standards for durability andhygiene, ensuring they can be safely reprocessed and reused. | |
| Reusability | • The subject device adheres to standards such as ISO 17664-2:2021, AAMI TIR12(2020)/(R)2023, and ANSI AAMI ST98:2022. Additionally, it complies with the"Reprocessing Medical Devices in Health Care Settings: Validation Methodsand Labeling" document issued by the FDA on March 17, 2015. |
| • The proposed reprocessing instructions for the subject device are as effective asthe predicate device. The subject device labeling meets all regulatoryrequirements and addresses any concerns related to reprocessing instructions forreusable devices. These instructions are consistent with state-of-the-art science toensure the device is clean and disinfected. | |
| Therefore, despite the difference in reusability, the subject device is substantiallyequivalent to the predicate device in terms of safety and effectiveness. |
Image /page/10/Picture/4 description: The image shows the Philips logo, which is a blue shield shape. Inside the shield, the word "PHILIPS" is written in white at the top. Below the word, there are two wavy lines and four stars, also in white. The logo is simple and recognizable, representing the brand's identity.
{11}------------------------------------------------
Image /page/11/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The background is white, which makes the blue letters stand out.
| Type of Lead setelectrode connector | The subject device, featuring lead wires with Grabber, Snap, and Mini clip connectors, is substantially equivalent to the predicate device, which utilizes Pinch and Snap connectors. |
|---|---|
| Purpose:Both devices connect patient electrodes to monitoring equipment, ensuring secure and reliable signal transmission. | |
| Technological Characteristics:Subject Device: Connectors (Grabber, Snap, Mini clip), medical-grade materials, flexible design. Predicate Device: Connectors (Pinch, Snap), medical-grade materials, flexible design. | |
| The Grabber and electrode Pinch have the same design but are named differently. The subject device includes a Mini clip, which is not present in the predicate device. | |
| The difference in the lead set electrode connector types is minor and does not raise different questions of safety and effectiveness, as performance testing addresses these differences. Therefore, the subject device is substantially equivalent to the predicate device. |
Image /page/11/Picture/4 description: The image shows the Philips logo. The logo is a blue shield shape with the word "PHILIPS" at the top. Inside the shield is a white circle with two wavy lines and four stars. The wavy lines are arranged horizontally, and the stars are placed symmetrically around the circle.
{12}------------------------------------------------
Image /page/12/Picture/0 description: The image shows the word "PHILIPS" in a bold, sans-serif font. The word is written in blue color. The background is white.
| Trunk cable toMonitor Connection | The subject device, featuring trunk cables with a 12-pin ECG connector for Philipsmonitors, is substantially equivalent to the predicate device, which uses 8-pin and 12-pin ECG connectors for Philips monitors.Purpose:Both devices connect trunk cables to Philips monitors, ensuring secure and reliablesignal transmission for ECG monitoring.Technological Characteristics:Subject Device: 12-pin ECG connector.Predicate Device: 8-pin and 12-pin ECG connectors.The subject device does not offer an 8-pin connector. Compatibility with Philipsmonitors depends on specific monitor specifications. Both devices use similar materialsand designs to ensure reliable connections.Performance Characteristics:Both devices meet standards for electrical conductivity, mechanical strength,and biocompatibility (ISO 10993-1).The subject device's absence of an 8-pin connector does not raise new questions ofsafety and effectiveness, this configuration is not offered in thissubmission. Performance testing confirms the trunk cables are safe and performas intended for use with Philips monitors. Therefore, the subject device issubstantially equivalent to the predicate device. |
|---|---|
| Lead WireConstruction | For neonate applications where the need for utmost cable flexibility exceeds a cableshield, Philips offers an unshielded 3-lead and 5-lead set. The monitor covers this casevia respective measurement input circuits, allowing the desired ECG signal to pass buteliminating the disturbing rest. This illustrates the monitor's final, overarchingresponsibility since measurement accuracy is finally defined on the system level. |
| Performance Testing | The subject device complies with the same performance standards as the predicatedevice. Additionally, subject device ICU Lead Sets and Trunk cables also comply withadditional performance standards i.e. IEC 60601-1-12. |
Image /page/12/Picture/4 description: The image shows the Philips logo. The logo is a blue shield shape with the word "PHILIPS" in white at the top. Inside the shield, there are two wavy lines and four stars. The wavy lines are white, and the stars are four-pointed.
{13}------------------------------------------------
Image /page/13/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The background is white, which makes the blue letters stand out.
Substantial Equivalence Summary
In accordance with 21 CFR Part 807, the Philips Reusable ECG Lead Sets and Trunk Cables are as safe and effective for their intended use as the Medline Patient Cables and Lead Wires (K181726). Both the predicate and reference devices share the same product code (DSA), ensuring similar FDA classification. As demonstrated in the sections above, the differences identified between the subject device and predicate device do not raise new questions of safety and effectiveness. Performance testing confirms that the Philips Reusable ECG Lead Sets and Trunk Cables are safe and performed as intended for Philips monitors.
The Medline Patient Cables and Lead Wires (K181726) serve as the predicate device, demonstrating the intended use of connecting patient electrodes to monitoring equipment and providing a basis for substantial equivalence comparison.
The Multi-Link X2 ECG Cable and Lead Wire System (K211294) serves as a reference device, supporting technological characteristics and further substantiating claims of equivalence.
Based on the above discussion, the differences in the technological characteristics of the subject and predicate devices do not raise new questions of safety and effectiveness. The subject device meets the predicate device's safety and performance standards. Additional performance standard (IEC 60601-1-12:2014 +AMD1:2020) met by the subject device's ICU Lead Sets and Trunk cables are identical to the one met by the reference device.
Performance Data
Non-Clinical Tests – Harmonized Standards
The subject devices have passed all safety tests for demonstrated compliance with the recognized standards below.
| Standard | FDARecognition # | Title # |
|---|---|---|
| IEC 60601-1:2005+A1:2012+A2:2020 | 19-49 | Medical electrical equipment –Part 1: General requirements forbasic safety and essential performance |
| ANSI AAMIEC53:2013/(R)2020 | 3-129 | ECG trunk cables and patient lead wires |
| IEC 60601-2-25:2011/(R)2016 | 3-105 | Medical electrical equipment - Part 2-25: Particularrequirements for the basic safety and essentialperformance of electrocardiographs |
| IEC 60601-2-27:2011(R)2016 | 3-126 | Medical electrical equipment - Part 2-27: Particular |
Image /page/13/Picture/12 description: The image shows the Philips logo, which is a shield-shaped emblem in blue and white. The word "PHILIPS" is written in blue at the top of the shield. Inside the shield, there are two wavy lines in white, resembling sound waves or water waves. Above and below the waves, there are four-pointed stars, also in white, adding a celestial or technological element to the design.
{14}------------------------------------------------
Image /page/14/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The letters are evenly spaced and appear to be a sans-serif font. The background is white, providing a strong contrast that makes the word easily readable.
| requirements for the basic safety and essentialperformance of electrocardiographicequipment | ||
|---|---|---|
| IEC 60601-1-12 Edition 1.12020-07 CONSOLIDATEDVERSION | 19-39 | Medical electrical equipment - Part 1-12: Generalrequirements for basic safety and essential performance -Collateral Standard: Requirements for medical electricalequipment and medical electrical systems intended for usein the emergency medical services environment |
| IEC 62366-1:2015+AMD1:2020: | 5-129 | Part 1: Application of usability engineering to medicaldevices |
Image /page/14/Picture/4 description: The image shows the Philips logo, which is a blue shield shape with the word "PHILIPS" written in white at the top. Inside the shield, there are two wavy lines and two stars. The logo is simple and recognizable, representing the brand's identity.
{15}------------------------------------------------
Image /page/15/Picture/0 description: The image shows the word "PHILIPS" in large, bold, blue letters. The font is sans-serif and the letters are evenly spaced. The word is centered and takes up most of the frame. The background is white.
Non-clinical Bench Tests
No new issues of safety or effectiveness are introduced because of using this device.
Clinical Studies
The subject devices, like the primary predicate devices, did not require clinical trials.
Compliance to the FDA Quality System Regulations, FDA recognized standards, FDA guidance documents, harmonized standards, verification and validation and risk management activities have taken place for the subject devices.
Based upon the design, intended use, indications for use, classification, usability and safety testing, the subject devices are substantially equivalent to the listed predicate devices.
No new issues of substantial equivalence are introduced as a result of using this device.
Conclusion
The results of the substantial equivalence assessment, taken together with non-clinical bench testing demonstrate that the subject devices do not raise different questions of safety and effectiveness when compared to the predicate, perform as intended, and have performance characteristics that are substantially equivalent to the predicate device.
Image /page/15/Picture/12 description: The image is the Philips logo. The logo is a blue shield with the word "PHILIPS" at the top. Inside the shield are two wavy lines and four stars. The stars are arranged in a diamond shape.
§ 870.2900 Patient transducer and electrode cable (including connector).
(a)
Identification. A patient transducer and electrode cable (including connector) is an electrical conductor used to transmit signals from, or power or excitation signals to, patient-connected electrodes or transducers.(b)
Classification. Class II (performance standards).